These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11603162)

  • 1. Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom.
    Tsolaki M; Kokarida K; Iakovidou V; Stilopoulos E; Meimaris J; Kazis A
    Am J Alzheimers Dis Other Demen; 2001; 16(5):268-78. PubMed ID: 11603162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease.
    Ellis RJ; Caligiuri M; Galasko D; Thal LJ
    Alzheimer Dis Assoc Disord; 1996; 10(2):103-14. PubMed ID: 8727172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of extrapyramidal signs in Alzheimer's disease.
    Tosto G; Monsell SE; Hawes SE; Mayeux R
    J Neurol; 2015 Nov; 262(11):2548-56. PubMed ID: 26338814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extrapyramidal signs in Alzheimer's disease].
    Pfeffer-Baczuk A; Barcikowska M; Karwańska A
    Neurol Neurochir Pol; 1996; 30(3):389-98. PubMed ID: 8965973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal signs in patients with probable Alzheimer disease.
    Lopez OL; Wisnieski SR; Becker JT; Boller F; DeKosky ST
    Arch Neurol; 1997 Aug; 54(8):969-75. PubMed ID: 9267971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor signs predict poor outcomes in Alzheimer disease.
    Scarmeas N; Albert M; Brandt J; Blacker D; Hadjigeorgiou G; Papadimitriou A; Dubois B; Sarazin M; Wegesin D; Marder K; Bell K; Honig L; Stern Y
    Neurology; 2005 May; 64(10):1696-703. PubMed ID: 15911793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of parkinsonian signs for gait and balance in patients with Alzheimer's disease of mild degree.
    Tangen GG; Bergland A; Engedal K; Mengshoel AM
    Gait Posture; 2017 Jan; 51():159-161. PubMed ID: 27770681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline.
    Franssen EH; Kluger A; Torossian CL; Reisberg B
    Arch Neurol; 1993 Oct; 50(10):1029-39. PubMed ID: 8215960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor signs during the course of Alzheimer disease.
    Scarmeas N; Hadjigeorgiou GM; Papadimitriou A; Dubois B; Sarazin M; Brandt J; Albert M; Marder K; Bell K; Honig LS; Wegesin D; Stern Y
    Neurology; 2004 Sep; 63(6):975-82. PubMed ID: 15452286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SPECT study of parkinsonism in Alzheimer's disease.
    Starkstein SE; Vazquez S; Merello M; Tesón A; Petracchi M; Leiguarda R
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):308-13. PubMed ID: 7580189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do extrapyramidal features in Alzheimer patients treated with acetylcholinesterase inhibitors predict disease progression?
    Brodaty H; Sachdev P; Berman K; Gibson L; Kemp NM; Cullen B; Burns A
    Aging Ment Health; 2007 Jul; 11(4):451-6. PubMed ID: 17612809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapyramidal motor abnormalities associated with late-life psychosis.
    Caligiuri MP; Lohr JB; Panton D; Harris MJ
    Schizophr Bull; 1993; 19(4):747-54. PubMed ID: 7905662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between functional impairment, depression, and extrapyramidal signs in neuroleptic-free patients with Alzheimer disease.
    Choi J; Myung W; Chung JW; Kang HS; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim S; Kim S; Carroll BJ; Kim DK
    J Geriatr Psychiatry Neurol; 2013 Sep; 26(3):144-50. PubMed ID: 23733855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease symptom severity in blacks and whites.
    Shadlen MF; Larson EB; Gibbons L; McCormick WC; Teri L
    J Am Geriatr Soc; 1999 Apr; 47(4):482-6. PubMed ID: 10203126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of daytime napping and Parkinsonian signs in Alzheimer's disease.
    Park M; Comella CL; Leurgans SE; Fan W; Wilson RS; Bennett DA
    Sleep Med; 2006 Dec; 7(8):614-8. PubMed ID: 17023213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates.
    Merello M; Sabe L; Teson A; Migliorelli R; Petracchi M; Leiguarda R; Starkstein S
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1503-9. PubMed ID: 7798981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.